Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
US Physical Therapy Analyst Ratings and Price Targets | NYSE:USPH | Benzinga
US Physical Therapy Inc has a consensus price target of $109 based on the ratings of 5 analysts. The high is $115 issued by B of A Securities on December 16, 2024. The low is $98 issued by Barrington Research on February 28, 2025. The 3 most-recent analyst ratings were released by JP Morgan, Barrington Research, and B of A Securities on March 19, 2025, February 28, 2025, and December 16, 2024, respectively. With an average price target of $107.67 between JP Morgan, Barrington Research, and B of A Securities, there's an implied 47.20% upside for US Physical Therapy Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
JP Morgan
Barrington Research
B of A Securities
JMP Securities
1calculated from analyst ratings
Analyst Ratings for US Physical Therapy
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/19/2025 | Buy Now | 50.39% | JP Morgan | Calvin Sternick48% | $120 → $110 | Maintains | Overweight | Get Alert |
| 02/28/2025 | Buy Now | 33.98% | Barrington Research | Michael Petusky52% | $108 → $98 | Maintains | Outperform | Get Alert |
| 12/16/2024 | Buy Now | 57.22% | B of A Securities | Joanna Gajuk65% | $100 → $115 | Upgrade | Neutral → Buy | Get Alert |
| 12/16/2024 | Buy Now | 54.49% | JMP Securities | Constantine Davides38% | → $113 | Initiates | → Market Outperform | Get Alert |
| 12/03/2024 | Buy Now | 64.06% | JP Morgan | Calvin Sternick48% | $117 → $120 | Maintains | Overweight | Get Alert |
| 11/21/2024 | Buy Now | 47.65% | Barrington Research | Michael Petusky52% | $108 → $108 | Maintains | Outperform | Get Alert |
| 11/07/2024 | Buy Now | 47.65% | Barrington Research | Michael Petusky52% | $108 → $108 | Maintains | Outperform | Get Alert |
| 10/09/2024 | Buy Now | 47.65% | Barrington Research | Michael Petusky52% | $108 → $108 | Maintains | Outperform | Get Alert |
| 10/07/2024 | Buy Now | 23.04% | B of A Securities | Joanna Gajuk65% | $114 → $90 | Downgrade | Buy → Neutral | Get Alert |
| 09/20/2024 | Buy Now | 47.65% | Barrington Research | Michael Petusky52% | $108 → $108 | Maintains | Outperform | Get Alert |
| 08/15/2024 | Buy Now | 47.65% | Barrington Research | Michael Petusky52% | $122 → $108 | Maintains | Outperform | Get Alert |
| 05/09/2024 | Buy Now | 66.79% | Barrington Research | Michael Petusky52% | $122 → $122 | Maintains | Outperform | Get Alert |
| 03/13/2024 | Buy Now | 59.96% | JP Morgan | Calvin Sternick48% | $99 → $117 | Maintains | Overweight | Get Alert |
| 03/01/2024 | Buy Now | 66.79% | Barrington Research | Michael Petusky52% | $120 → $122 | Maintains | Outperform | Get Alert |
| 01/03/2024 | Buy Now | 64.06% | Barrington Research | Michael Petusky52% | $111 → $120 | Maintains | Outperform | Get Alert |
| 11/17/2023 | Buy Now | 35.35% | JP Morgan | Calvin Sternick48% | $108 → $99 | Maintains | Overweight | Get Alert |
| 11/09/2023 | Buy Now | 51.75% | Barrington Research | Michael Petusky52% | $124 → $111 | Maintains | Outperform | Get Alert |
| 09/22/2023 | Buy Now | 47.65% | JP Morgan | Calvin Sternick48% | → $108 | Initiates | → Overweight | Get Alert |
| 09/19/2023 | Buy Now | — | CJS Securities | Larry Solow45% | — | Upgrade | Market Perform → Market Outperform | Get Alert |
| 08/14/2023 | Buy Now | 69.53% | Barrington Research | Michael Petusky52% | $116 → $124 | Maintains | Outperform | Get Alert |
| 06/30/2023 | Buy Now | 88.67% | B of A Securities | Joanna Gajuk65% | → $138 | Initiates | → Buy | Get Alert |
| 05/05/2023 | Buy Now | 58.59% | Barrington Research | Michael Petusky52% | $110 → $116 | Maintains | Outperform | Get Alert |
| 02/24/2023 | Buy Now | 50.39% | Barrington Research | Michael Petusky52% | $107 → $110 | Maintains | Outperform | Get Alert |
FAQ
What is the target price for US Physical Therapy (USPH) stock?
The latest price target for US Physical Therapy (NYSE:USPH) was reported by JP Morgan on March 19, 2025. The analyst firm set a price target for $110.00 expecting USPH to rise to within 12 months (a possible 50.39% upside). 12 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for US Physical Therapy (USPH)?
The latest analyst rating for US Physical Therapy (NYSE:USPH) was provided by JP Morgan, and US Physical Therapy maintained their overweight rating.
When was the last upgrade for US Physical Therapy (USPH)?
The last upgrade for US Physical Therapy Inc happened on December 16, 2024 when B of A Securities raised their price target to $115. B of A Securities previously had a neutral for US Physical Therapy Inc.
When was the last downgrade for US Physical Therapy (USPH)?
The last downgrade for US Physical Therapy Inc happened on October 7, 2024 when B of A Securities changed their price target from $114 to $90 for US Physical Therapy Inc.
When is the next analyst rating going to be posted or updated for US Physical Therapy (USPH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of US Physical Therapy, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for US Physical Therapy was filed on March 19, 2025 so you should expect the next rating to be made available sometime around March 19, 2026.
Is the Analyst Rating US Physical Therapy (USPH) correct?
While ratings are subjective and will change, the latest US Physical Therapy (USPH) rating was a maintained with a price target of $120.00 to $110.00. The current price US Physical Therapy (USPH) is trading at is $73.15, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.